General Information
Drug ID
DR00401
Drug Name
Talinolol
Synonyms
(+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin]
Drug Type
Small molecular drug
Indication Gastrointestinal motility disorder [ICD11: DE2Z] Phase 1 [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=68770"></iframe>
3D MOL 2D MOL
Formula
C20H33N3O3
Canonical SMILES
CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O
InChI
InChI=1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25)
InChIKey
MXFWWQICDIZSOA-UHFFFAOYSA-N
CAS Number
CAS 57460-41-0
Pharmaceutical Properties Molecular Weight 363.502 Topological Polar Surface Area 82.6
Heavy Atom Count 26 Rotatable Bond Count 8
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 4
PubChem CID
68770
PubChem SID
103096738 , 103401016 , 104343015 , 107929351 , 117537352 , 124580994 , 125712702 , 126580194 , 126725781 , 126737449 , 127339737 , 127339738 , 127339739 , 131492773 , 135027207 , 135066580 , 135555209 , 135653641 , 135707467 , 135888304 , 136895027 , 137114987 , 142640331 , 144205724 , 14926104 , 162057748 , 162118068 , 162848586 , 164765202 , 165745358 , 170466514 , 170558731 , 178101379 , 179323274 , 184547412 , 202554924 , 215742084 , 226457382 , 252091637 , 252492541 , 26757961 , 43125295 , 50060575 , 50068853 , 51091522 , 57317059 , 77170990 , 8192333 , 95612779 , 98940985
ChEBI ID
CHEBI:135533
TTD Drug ID
D05JKG
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [3]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [4]
P-GP Transporter Info P-glycoprotein 1 Substrate [5]
References
1 ClinicalTrials.gov (NCT01635608) Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water
2 FDA Drug Development and Drug Interactions
3 Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp). Pharm Res. 2009 Mar;26(3):560-7.
4 Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J Pharmacol Exp Ther. 2010 Jan;332(1):181-9.
5 Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J Pharm Sci. 2007 Oct;96(10):2808-17.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.